维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

17篇 您的检索式：作者名="Jadersten M"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression 显示文摘	Jadersten M Salt L Pellagatti A	2009	Haematologica2009，94，12：	1
	2	Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome显示文摘	JADERSTEN M MALCOVATI L DYBEDAL I	2008	J Clin Oncol2008，26，：	1
	3	Lenalidomide inhib- its the malignant clone and up-regulates the SPRAC gene mapping to the commonly deleted region in 5q-syndrome patients显示文摘	Pellagatti A Jadersten M Forsblom AM	2007	Proc Natl Acad Sci U S A2007，104，11：	1
	4	Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome显示文摘	JADERSTEN M MALCOVATI L DYBEDAL I	2008	J Clin Oncol2008，26，：	1
	5	Long- term outcome of treatment of anemia in MDS with erythropoietin and G-CSF 显示文摘	Jadersten M Montgomery S M Dybedal I	2005	Blood2005，106，3：	1
	6	Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF显示文摘	Jadersten M Montgomery SM Dybedal I	2005	Blood2005，106，3：	1
	7	Lenalidomide inhibits the malignant clone and upregulates the SPRAC gene mapping to the commonly deleted region in 5q-syndrome patients显示文摘	PELLAGATTI A JADERSTEN M FORSBLOM A M	2007	Proc Natl AcaedSci USA2007，104，11：	1
	8	Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome显示文摘	Jadersten M Malcovati L Dybedal I	2008	J Clin Oncol2008，26，：	1
	9	Treatment with erythropoietin and G-CSF improves survival in MDS patients with low transfusion need显示文摘	JaDERSTEN M MALCOVATI L DYBEDAL I	2006	Blood2006，106，：	1
	10	Lenalidomide inhib-its the malignant clone and up-regulates the SPARC gene mapping tothe commonly deleted region in 5q-syndrome patients 显示文摘	Pellagatti A Jadersten M Forsblom AM	2007	Proc NatlAcad Sci USA2007，104，11：	1
	11	Erythropoietin and granuloeyte- colony stimulating factor treatment associated with improved survival in myelodysplastie syndrome显示文摘	Jadersten M Maleovati L Dybedal I	2008	J Clin Oncol2008，26，21：	1
	12	Clonal heteroge?neity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at dis?ease progression显示文摘	Jadersten M Saft L Pellagatti A	2009	Haematologica2009，94，12：	1
	13	New clues to the molecular pathogenesls of myelodysplastic syndromes显示文摘	Jadersten M Hellstrom Lindberg E	2010	Exp Cell Res2010，316，8：	1
	14	Long-term outcome of treatment of anemia in MDS with erythro-poietin and G-CSF显示文摘	Jadersten M Montgomery SM Dybedal l	2005	Blood2005，106，3：	1
	15	Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q-syndrome patients 显示文摘	Pellagatti A Jadersten M Forsblom AM	2007	Proc NatlAcadSciU SA2007，104，11：	1
	16	Erythropoietin and gran- ulocytecolony stimulating factor treatment associated with improved survival in myelodysplastic syndrome 显示文摘	Jadersten M Malcovati L Dybedal I	2008	J Clin Oncol2008，26，21：	1
	17	Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF显示文摘	Jadersten M Montgomery SM Dybedal I	2005	Blood2005，106，3：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费